Clinical Trial Update: Effect of Heliox on RSV Bronchiolitis [Phase 3]

View source ↗

Summary

A Phase 3 trial assessing the effect of heliox on respiratory syncytial virus bronchiolitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis
• Respiratory Syncytial Virus Infection

Drugs mentioned

• Heliox (helium-oxygen mixture)

Snippet

Sponsor: Wael Seliem | Conditions: RSV Infection, Acute Bronchiolitis | Phase 3 | Status: COMPLETED